Research article
Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging
Ging-Yuek R. Hsiung, A. Dessa Sadovnick and Howard Feldman
CMAJ October 12, 2004 171 (8) 863-867; DOI: https://doi.org/10.1503/cmaj.1031789
Ging-Yuek R. Hsiung
A. Dessa Sadovnick
Data supplements
Online Tables
Files in this Data Supplement:
Related Articles
- (2004). Highlights of this issue. CMAJ, 171(8), 825. Accessed August 03, 2024. Retrieved from http://www.cmaj.ca/content/171/8/825.
- Gauthier, S. (2004). The benefits of apolipoprotein E ε4 screening to research. CMAJ, 171(8), 881. Accessed August 03, 2024. https://doi.org/10.1503/cmaj.1041189.
In this issue
CMAJ
Vol. 171, Issue 8
12 Oct 2004
Article tools
Respond to this article
Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging
Ging-Yuek R. Hsiung, A. Dessa Sadovnick, Howard Feldman
CMAJ Oct 2004, 171 (8) 863-867; DOI: 10.1503/cmaj.1031789
Jump to section
Related Articles
Cited By...
- Effect of APOE {varepsilon}4 and its modification by sociodemographic characteristics on cognitive measures in South Asians from LASI-DAD
- EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimers disease
- Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments
- Predictive value of APOE-{varepsilon}4 allele for progression from MCI to AD-type dementia: a meta-analysis
- Joint effect of stroke and APOE 4 on dementia risk: The Canadian Study of Health and Aging
- Conversion to dementia from mild cognitive disorder: the Cache County Study.
- The benefits of apolipoprotein E {epsilon}4 screening to research